Orthonotes
Orthonotes
by the.bonestories
v3.0 Fusion
v3.0 Fusion
PubMed Original Article Evidence Unclassified

Articular Cartilage Regeneration in Veterinary Medicine.

Advances in experimental medicine and biology | 2022 | Voga M, Majdic G

In-App Reader

Open Source

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Source
PubMed
Type
Original Article
Evidence
Unclassified

Abstract

[Indexed for MEDLINE] 9. Cartilage. 2021 Jul;12(3):307-319. doi: 10.1177/1947603519835898. Epub 2019 Mar 17. High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects. López-Alcorocho JM(1), Guillén-Vicente I(1), Rodríguez-Iñigo E(1), Navarro R(1), Caballero-Santos R(1), Guillén-Vicente M(1), Casqueiro M(1), Fernández-Jaén TF(1), Sanz F(1), Arauz S(1), Abelow S(1), Guillén-García P(1). Author information: (1)Department of Traumatology and Research Unit, Clínica CEMTRO, Madrid, Spain. PURPOSE: Two-year follow-up to assess efficacy and safety of high-density autologous chondrocyte implantation (HD-ACI) in patients with cartilage lesions in the ankle. DESIGN: Twenty-four consecutive patients with International Cartilage repair Society (ICRS) grade 3-4 cartilage lesions of the ankle were included. Five million chondrocytes per cm2 of lesion were implanted using a type I/III collagen membrane as a carrier and treatment effectiveness was assessed by evaluating pain with the visual analogue scale (VAS) and American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score at baseline, 12-month, and 24-month follow-up, together with dorsal and plantar flexion. Magnetic resonance observation for cartilage repair tissue (MOCART) score was used to evaluate cartilage healing. Histological study was possible in 5 cases. RESULTS: Patients' median age was 31 years (range 18-55 years). Median VAS score was 8 (range 5-10) at baseline, 1.5 (range 0-8) at 12-month follow-up, and 2 (rang e0-5) at 24-month follow-up (P < 0.001). Median AOFAS score was 39.5 (range 29-48) at baseline, 90 (range 38-100) at 12-month follow-up, and 90 (range 40-100) at 24-month follow-up (P < 0.001). Complete dorsal flexion significantly increased at 12 months (16/24, 66.7%) and 24 months (17/24, 70.8%) with regard to baseline (13/24, 54.2%) (P = 0.002). MOCART at 12- and 24-month follow-ups were 73.71 ± 15.99 and 72.33 ± 16.21. Histological study confirmed that neosynthetized tissue was cartilage with hyaline extracellular matrix and numerous viable chondrocytes. CONCLUSION: HD-ACI is a safe and effective technique to treat osteochondral lesions in the talus, providing good clinical and histological results at short- and mid-term follow-ups. DOI: 10.1177/1947603519835898 PMCID: PMC8236657

Linked Wiki Topics

This article has not been linked to a wiki topic yet.

Linked Cases

This article has not been linked to a case yet.

Linked Atlases

This article has not been linked to an atlas yet.